Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacillus Anthracis (Anthrax)”

16 trials

Showing 16 of 16 results

Large-scale testing (Phase 3)Study completedNCT02016963
What this trial is testing

An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

Who this might be right for
Therapeutic Treatment of Inhalation Anthrax
Human Genome Sciences Inc. 20
Early research (Phase 1)Study completedNCT00138411
What this trial is testing

Monoclonal Antibody for Treatment of Inhalation Anthrax

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Study completedNCT01641991
What this trial is testing

Assessment of the Immunogenicity and Safety of a Dose-Sparing BioThrax® AVA Schedule

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 328
Not applicableNot Yet RecruitingNCT03569514
What this trial is testing

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

Who this might be right for
Anthrax
Emergent BioSolutions 10
Not applicableNot Yet RecruitingNCT07268612
What this trial is testing

Evaluation of Clinical Benefit and Safety Following CYFENDUS Administration for Post-Exposure Prophylaxis of Anthrax Disease.

Who this might be right for
Anthrax
Emergent BioSolutions 250
Not applicableStudy completedNCT03498027
What this trial is testing

Febrile Whole Blood Specimen Collection and Testing

Who this might be right for
Febrile InfectionAnthrax
MRI Global 97
Large-scale testing (Phase 3)Study completedNCT03877926
What this trial is testing

VELOCITY: An Anthrax Vaccine Clinical Study

Who this might be right for
Anthrax
Emergent BioSolutions 3,689
Testing effectiveness (Phase 2)Ended earlyNCT00133484
What this trial is testing

UMD rPA Regimen Trial in Adults

Who this might be right for
Bacillus Anthracis (Anthrax)
National Institute of Allergy and Infectious Diseases (NIAID) 270
Early research (Phase 1)Study completedNCT01263691
What this trial is testing

Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults

Who this might be right for
Bacillus Anthracis (Anthrax) Infection
Emergent BioSolutions 105
Testing effectiveness (Phase 2)Study completedNCT04067011
What this trial is testing

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

Who this might be right for
Anthrax
Emergent BioSolutions 210
Not applicableNot Yet RecruitingNCT03569553
What this trial is testing

A Field Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Inhalational Anthrax Patients

Who this might be right for
Inhalational Anthrax
Emergent BioSolutions 100
Testing effectiveness (Phase 2)Study completedNCT00170469
What this trial is testing

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Who this might be right for
Bacillus Anthracis (Anthrax)
PharmAthene UK Limited 226
Early research (Phase 1)Study completedNCT00063843
What this trial is testing

Anthrax-rPA: Safety, Tolerability, Immunogenicity

Who this might be right for
Anthrax
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableEnded earlyNCT05672875
What this trial is testing

Evaluation of the SRI B. Anthracis Lethal Factor Diagnostic System

Who this might be right for
Anthrax
SRI International 343
Post-approval studies (Phase 4)UnknownNCT03088111
What this trial is testing

An Open Label Field Study of Anthim (Obiltoxaximab) in Subjects Exposed to B. Anthracis

Who this might be right for
Infection, BacterialAnthrax
Elusys Therapeutics 100
Testing effectiveness (Phase 2)Study completedNCT00170456
What this trial is testing

Phase II Study of Range and Schedule of rPA Doses

Who this might be right for
Prevention of Bacillus Anthracis (Anthrax) Infection
PharmAthene UK Limited 415

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation